Discuss This Drug

doconexent, calcium citrate, pyridoxine hydrochloride, ferrous fumarate, carbonyl iron, folic acid, cholecalciferol, dl-alpha tocopheryl acetate

CHEBI:CHEBI_753751

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
active_ingredient_strength
62.06 mg/1
dosage_form
CAPSULE, LIQUID FILLED
active_ingredient_name
.ALPHA.-TOCOPHEROL ACETATE, DL-
marketing_start_date
20170929
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Catalent Ontario Limited
package_marketing_start_date
29-SEP-17
generic_name
doconexent, calcium citrate, pyridoxine hydrochloride, ferrous fumarate, carbonyl iron, folic acid, cholecalciferol, dl-alpha tocopheryl acetate
product_ndc
61474-4296
spl_id
fe08581c-e7d9-5798-e053-6394a90a4f42
package_ndc
61474-4296-1
package_description
2 BAG in 1 CARTON (61474-4296-1) / 4000 CAPSULE, LIQUID FILLED in 1 BAG
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class